Clinical Trial Update: AB154 Combined With AB122 for Recurrent Glioblastoma [EARLY_Phase 1]

View source ↗

Summary

A phase 1 trial evaluating AB154 in combination with AB122 for recurrent Glioblastoma; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• AB122
• AB154

Snippet

Sponsor: Yale University | Conditions: Glioblastoma | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING